News & Comment

The cancer nanomedicine field is heading in two directions — debating whether the clinical translation of nanomaterials should be accelerated or whether some of the long-standing drug delivery paradigms have to be challenged first.

The regulatory approval of Onpattro, a lipid nanoparticle-based short interfering RNA drug for the treatment of polyneuropathies induced by hereditary transthyretin amyloidosis, paves the way for clinical development of many nucleic acid-based therapies enabled by nanoparticle delivery.

The coordinating role of the National Nanotechnology Initiative will be essential for the development of research at the nanoscale in the next decades.

As new nanomaterials, manufacturing methods and applications advance, the nanotechnology-related environmental, health and safety community is well positioned to build upon the scientific foundation and strong collaborations they have developed to further expand understanding and ensure responsible development into the future.

The experiences gained from the past 15 years of nanomaterial risk analysis may be useful for the risk analysis efforts of other emerging technologies.

After 15 years of intensive academic research, graphene is getting ready to morph into a marketable technology.

Fifteen years since the ground-breaking experiments on graphene, its commercial exploitation is progressing at the expected pace for a new material.

Looking back at some of the key discoveries that shaped the field.

Visiting a research centre specialized in nanoscience and nanotechnology can be an inspiration for students in other disciplines, as Chris Toumey explains.

Graphene is being used commercially in large quantities in ways that are grounded in market realities, far from the much hyped ‘killer applications’.

An EU-funded open call aims at building a consortium to bridge basic and applied research on graphene and related atomically thin crystals for the development of integrated circuit technologies.

The trade-off between necessary scientific communication and the associated CO₂ footprint asks for a thorough reconsideration of our travelling habits, new institutional travelling policies and for alternative approaches to interaction with colleagues and peers.

Channelling chemical intuition to conquer larger scales.